BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591
129 results:

  • 1. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study.
    Yamazaki H; Streicher SA; Wu L; Fukuhara S; Wagner R; Heni M; Grossman SR; Lenz HJ; Setiawan VW; Le Marchand L; Huang BZ
    Cell Rep Med; 2024 Feb; 5(2):101391. PubMed ID: 38280379
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing.
    Alahmari AA; Chaubey AH; Jonnakuti VS; Tisdale AA; Schwarz CD; Cornwell AC; Maraszek KE; Paterson EJ; Kim M; Venkat S; Gomez EC; Wang J; Gurova KV; Yalamanchili HK; Feigin ME
    RNA; 2024 Feb; 30(3):281-297. PubMed ID: 38191171
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association Between a History of Breast cancer and Decreased Thyroid cancer-specific Mortality.
    Lin S; Wang Z; Xing M
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Machine learning-based prediction models for parathyroid carcinoma using pre-surgery cognitive function and clinical features.
    Wang Y; Wei B; Zhao T; Shen H; Liu X; Wang J; Wang Q; Shen R; Feng D
    Sci Rep; 2023 Nov; 13(1):19007. PubMed ID: 37923800
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma.
    Miyagawa Y; Kitazawa M; Tokumaru S; Nakamura S; Koyama M; Yamamoto Y; Miyazaki S; Hondo N; Soejima Y
    Oncology; 2024; 102(2):114-121. PubMed ID: 37699374
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Performance of CT-based deep learning in diagnostic assessment of suspicious lateral lymph nodes in papillary thyroid cancer: a prospective diagnostic study.
    Zheng G; Zhang H; Lin F; Zafereo M; Gross N; Sun P; Liu Y; Sun H; Wu G; Wei S; Wu J; Mao N; Li G; Wu G; Zheng H; Song X
    Int J Surg; 2023 Nov; 109(11):3337-3345. PubMed ID: 37578434
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma.
    Deza S; Maroto J; Tellechea O; Orbegozo N; Merino J; Galofré JC; Alegre E; González Á
    Clin Chim Acta; 2023 Aug; 548():117502. PubMed ID: 37516333
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
    Yartsev VD; Atkova EL; Ekaterinchev MA
    Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis.
    Hendrikse CSE; Theelen PMM; van der Ploeg P; Westgeest HM; Boere IA; Thijs AMJ; Ottevanger PB; van de Stolpe A; Lambrechts S; Bekkers RLM; Piek JMJ
    Gynecol Oncol; 2023 Apr; 171():83-94. PubMed ID: 36841040
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Analysis and Comparison of the Malignant Thyroid Nodules Not Recommended for Biopsy in ACR TIRADS and AI TIRADS With a Large Sample of Surgical Series.
    Cui Y; Fu C; Si C; Li J; Kang Y; Huang Y; Cui K
    J Ultrasound Med; 2023 Jun; 42(6):1225-1233. PubMed ID: 36394431
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An artificial intelligence ultrasound system's ability to distinguish benign from malignant follicular-patterned lesions.
    Xu D; Wang Y; Wu H; Lu W; Chang W; Yao J; Yan M; Peng C; Yang C; Wang L; Xu L
    Front Endocrinol (Lausanne); 2022; 13():981403. PubMed ID: 36387869
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Real-life clinical impact of a five-tiered classification of pituitary tumors.
    Sahakian N; Appay R; Resseguier N; Graillon T; Piazzola C; Laure C; Figarella-Branger D; Régis J; Castinetti F; Brue T; Dufour H; Cuny T
    Eur J Endocrinol; 2022 Dec; 187(6):893-904. PubMed ID: 36315463
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.
    Kim SI; Kim JH; Lee S; Cho H; van Driel WJ; Sonke GS; Bristow RE; Park SY; Fotopoulou C; Lim MC
    Gynecol Oncol; 2022 Dec; 167(3):547-556. PubMed ID: 36273925
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of benign and malignant thyroid nodules based on dynamic AI ultrasound intelligent auxiliary diagnosis system.
    Wang B; Wan Z; Li C; Zhang M; Shi Y; Miao X; Jian Y; Luo Y; Yao J; Tian W
    Front Endocrinol (Lausanne); 2022; 13():1018321. PubMed ID: 36237194
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
    Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
    Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Trends in Adjuvant External Beam Radiation Therapy for Nonanaplastic Thyroid cancer in California, 2003-2017.
    Hu MY; Chin RK; Kim J; Tseng CH; Yeh MW; Livhits MJ; Leung AM; Wu JX
    Endocr Pract; 2022 Jul; 28(7):647-653. PubMed ID: 35231653
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Meta-analysis of the efficacy and safety of thermal ablation for treating large benign thyroid nodules.
    Ji X; Sun W; Lv C; Huang J; Zhang H
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):654-663. PubMed ID: 35170792
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Correlation between YAP and RhoA Expression in Prostate and Ovarian Tumor Stroma.
    Lee MJ; Kim D
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):281-285. PubMed ID: 35092398
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Application of serum markers in medullary thyroid carcinoma].
    Han XD; Lu RQ; Hu HY; Guo L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1468-1474. PubMed ID: 34963245
    [No Abstract]    [Full Text] [Related]  

  • 20. Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.
    Manning-Geist BL; Gordhandas SB; Giri DD; Iasonos A; Zhou Q; Girshman J; O'Cearbhaill RE; Zamarin D; Lichtman SM; Sabbatini PJ; Tew WP; Li K; McDonnell AS; Aviki EM; Chi DS; Aghajanian CA; Grisham RN
    Gynecol Oncol; 2022 Jan; 164(1):12-17. PubMed ID: 34763937
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.